SCHEMBL20076264

SCHEMBL20076264

CCC(C)(C)CCCN1CCN(CCO)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 3/20 0.38
HPGD P15428 2/20 0.38
GAA P10253 2/20 0.38
POLB P06746 1/20 0.38
THRB P10828 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 4/20 0.38
HTT P42858 1/20 0.38
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HSD17B10 Q99714 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
CHRM4 P08173 2/20 0.35
CHRM5 P08912 2/20 0.35
CHRM3 P20309 2/20 0.35
CHRM2 P08172 2/20 0.35
CHRM1 P11229 2/20 0.35
HTR1A P08908 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20076338 0.88 ALDH1A1 (0.42) ALDH1A1KDM4ELMNAHPGDGAA
SCHEMBL20076261 0.84 KDM1A (0.36) ALDH1A1KDM4ECHRM4CHRM5CHRM3
SCHEMBL18737015 0.84 CHRM4 (0.44) ALDH1A1HPGDCHRM4CHRM5CHRM3
SCHEMBL15183486 0.82 ALDH1A1 (0.43) ALDH1A1KDM4ELMNAHPGDGAA
SCHEMBL18737047 0.82 HRH3 (0.46) KDM4ELMNACHRM4CHRM5CHRM3
SCHEMBL18649626 0.80 HRH3 (0.50) KDM4ELMNACHRM4CHRM5CHRM3
SCHEMBL19861182 0.78 CXCR4 (0.47) ALDH1A1LMNAPOLBKMT2AHSD17B10
SCHEMBL19861401 0.78 PAOX (0.43) ALDH1A1HPGDCHRM4CHRM5CHRM3
SCHEMBL22942482 0.78 GNAO1 (0.42) ALDH1A1KDM4ELMNAHPGDGAA
SCHEMBL19861431 0.78 ALDH1A1 (0.37) ALDH1A1TSHRCHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10647747-B2 Cyclosporin derivatives and uses thereof S&T GLOBAL INC. (US) 2020-05-12 US disclosed
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF S&T GLOBAL INC. 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10647747-B2 Cyclosporin derivatives and uses thereof FKBP5, FKBP1B, MALT1 ALDH1A1 2350/4885KDM4E 3207/4885LMNA 2857/4885
US-20180105558-A1 NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF FKBP1B, MALT1, FKBP5 ALDH1A1 2376/4885KDM4E 3214/4885LMNA 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.